Mizuho Securities Cuts Price Target on Myriad Genetics (MYGN) to $22 Following 4Q and Guidance

Go back to Mizuho Securities Cuts Price Target on Myriad Genetics (MYGN) to $22 Following 4Q and Guidance
Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 4.14 +0.28 (7.25%)
Previous Close $3.86    52 Week High $45.34 
Open $3.88    52 Week Low $15.92 
Day High $4.17    P/E 1.78 
Day Low $3.75    EPS $2.33 
Volume 2,830,846